Author + information
- Received January 12, 2015
- Revision received January 29, 2015
- Accepted January 29, 2015
- Published online August 1, 2015.
- Nadira B. Hamid, MD∗,
- Omar K. Khalique, MD∗,
- Mark J. Monaghan, PhD†,
- Susheel K. Kodali, MD∗,
- Danny Dvir, MD‡,
- Vinayak N. Bapat, MD§,
- Tamim M. Nazif, MD∗,
- Torsten Vahl, MD∗,
- Isaac George, MD∗,
- Martin B. Leon, MD∗ and
- Rebecca T. Hahn, MD∗∗ ()
- ∗Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York
- †King’s College Hospital, London, United Kingdom
- ‡St. Paul’s Hospital, Vancouver, British Columbia, Canada
- §Department of Cardiothoracic Surgery and Cardiology, Guys and St. Thomas’ Hospital, London, United Kingdom
- ↵∗Reprint requests and correspondence:
Dr. Rebecca T. Hahn, Columbia University Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, New York, New York 10032.
An increased use of bioprosthetic heart valves has stimulated an interest in possible transcatheter options for bioprosthetic valve failure given the high operative risk. The encouraging results of transcatheter aortic valve implantation in high-risk surgical candidates with native disease have led to the development of the transcatheter valve-in-valve (VIV) procedures for failed bioprostheses. VIV procedures are unique in many ways, and there is an increased need for multimodality imaging in a team-based approach. The echocardiographic approach to VIV procedures has not previously been described. In this review, we summarize key echocardiographic requirements for optimal patient selection, procedural guidance, and immediate post-procedural assessment for VIV procedures.
Dr. Khalique is a consultant for Edwards Lifesciences. Dr. Monaghan is a proctor for Edwards Lifesciences; and a speaker for Philips Healthcare and GE Medical. Dr. Kodali has received consulting fees from Edwards Lifesciences; is on the scientific advisory boards of Thubrikar Aortic Valve, Inc., and Meril Life Sciences; and has equity in Thubrikar Aortic Valve, Inc. Dr. Dvir is a consultant to Edwards Lifesciences; and has received an honorarium and research grant from Medtronic. Dr. Bapat is a consultant to Edwards Lifesciences, Boston Scientific, and Medtronic. Dr. Nazif has received consulting fees from Edwards Lifesciences and Medtronic. Dr. George is a member of the Data and Safety Monitoring Board of Tendyne Medical. Dr. Leon is a nonpaid member of the Scientific Advisory Board of Edwards Lifesciences. Dr. Hahn has core lab contracts with Edwards Lifesciences for which she receives no direct compensation; and is a speaker for Philips Healthcare, St. Jude Medical, and Boston Scientific. Drs. Hamid and Vahl have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received January 12, 2015.
- Revision received January 29, 2015.
- Accepted January 29, 2015.
- American College of Cardiology Foundation